Health and Wellness
The continuous glucose monitoring biosensor platform will use the funds to scale its manufacturing, move toward regulatory approval and perform more clinical trials.
Also, Lunit has completed its acquisition of breast screening AI company Volpara.
WellSpan Philhaven will add the digital health company's offerings to its suite of behavioral health services to support its primary care providers.
Caregivers can order rides and deliveries for their care recipients and pay for the service using the care receiver's health benefits.
Also, Optiscan is working with Mayo Clinic to develop a digital endomicroscopic imaging system for robotic surgery.
The company said its drugs will be more accessible than brand-name versions thanks to a partnership with a manufacturer of generic and 503B compounded injectables.
The launch of the WayFinding platform comes just weeks after the company announced it secured $126 million in funding.
Whole Health Rx will be powered by WellSync, which develops customizable telehealth services for businesses.
The organizations will codevelop an atrial fibrillation program that provides clinical decision support tools and patient coaching between clinical visits.
HIMSS24
Dr. Maulik Majmudar, Biofourmis chief medical officer, discusses the company's home-healthcare delivery tools and how to ensure remote patient monitoring technology is user-friendly for patients and effectively gathers data for providers.